Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

XERO LIMITED Director's Dealing 2015

Mar 2, 2015

66106_rns_2015-03-02_b5e2295c-bb78-4542-9d23-0ef6039dc9c4.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Xero Limited (XRO)
Date this disclosure made: March 2015
Date of last disclosure: Not applicable
Director or senior manager giving disclosure
Full name(s): Andy Lark
Name of listed issuer: Xero Limited (XRO)
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Chief Marketing Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:
Nature of the affected relevant interest(s):
For that relevant interest-
Number held in class before acquisition or disposal:
Number held in class after acquisition or disposal:
Current registered holder(s):
Registered holder(s) once transfers are registered:

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: Not applicable
Class of underlying financial products: Not applicable
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any):
Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price specified in the terms of the derivative (if any): Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
Not applicable
For that derivative.-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Not applicable
Unlisted conditional
contractual right to be issued
Ordinary Shares in Xero
Limited (Restricted Stock
Units or RSUs)
RSUs, subject to the terms of
the Xero Limited Restricted
Stock Unit Plan (AU) (Plan).
70,000 of the RSUs granted
will vest (meaning that an
equivalent number of
Ordinary Shares in Xero
Limited will be issued) (Vest)
in three parts on each of 31
March 2015, 31 March 2016.
and 31 March 2017 (20%;
40%; 40%), subject to the
terms of the Plan, including
continued employment of the
employee with the Xero
Limited Group, and the
satisfaction of certain
performance hurdles, on
each vesting date. 5,250 of
the RSUs will Vest in three
equal parts on each of 31
March 2015, 31 March 2016,
and 31 March 2017, subject
to the terms of the Plan.
including continued
employment of the employee
with the Xero Limited Group
on each vesting date (no
performance hurdles).
None
75,250
Not applicable
Andy Lark

l.

٦

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates:

$\sqrt{1}$

$\hat{\lambda}$

Details of transactions requiring disclosure
Details of trailsactions requiring disclosure-
Date of transaction: 25 February 2015
Nature of transaction: Allocation of RSUs under the
Xero Limited Restricted Stock
Unit Plan (AU).
Name of any other party or parties to the transaction (if known): Not applicable
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash
value, describe the consideration:
The RSUs have been
granted pursuant to the Xero
Limited Restricted Stock Unit
Plan (AU) as part of the
remuneration package of
Andy Lark in his role as Chief
Marketing Officer of Xero
Limited. The RSUs are
subject to certain conditions
in order to vest (as described
above). No cash
consideration is required to
be paid for the RSUs to vest.
Number of financial products to which the transaction related: 1
If the issuer has a financial products trading policy that prohibits directors or senior managers
from trading during any period without written clearance (a closed period) include the following
details-
Whether relevant interests were acquired or disposed of during a closed period: Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed
during the closed period:
Not applicable
Date of the prior written clearance (if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Not applicable
Nature of relevant interest: Not applicable
For that relevant interest.-
Number held in class: Not applicable
Current registered holder(s): Not applicable
For a derivative relevant interest.-
Type of derivative: Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products
(if any);
Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price's specified terms (if any): Not applicable
Any other details needed to understand how the amount of the consideration payable under the
derivative or the value of the derivative is affected by the value of the underlying financial
products:
Not applicable
For that derivative relevant interest,-
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest
in the derivative:
Not applicable

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Andrewsbark

Date of signature: